CompletedPHASE2, PHASE3NCT00445120

Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment

Studying Vernal keratoconjunctivitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Campus Bio-Medico University
Principal Investigator: Stefano Bonini, MD
University Campus Bio-Medico
Intervention: Lactobacillus Rhamnosus GG(drug)
Enrollment: 48 enrolled
Eligibility: 5-16 years · All sexes
Timeline: 2007 – 2009

Study locations (3)

University of Genova, Genova, Italy
University of Padua, Padua, Italy
University Campus Bio-Medico, Rome, Italy

Collaborators

University of Genova · University of Padova

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00445120 on ClinicalTrials.gov

Other trials for Vernal keratoconjunctivitis

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT06913790
Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids
Superior University

See all trials for Vernal keratoconjunctivitis →

← Back to all trials